Agios Pharmaceuticals, Inc. (AGIO) earnings
AGIO earnings moved a median of +1.38% by the close. Quarterly and annual AGIO reports and results, each read against the price at its own news timestamp. Back to the AGIO overview →
29 measured AGIO earnings events.
Where these AGIO earnings landedvs 29 measured AGIO earnings reactions
| Middle 50% of AGIO earnings reactions | -0.54% to +2.95% |
|---|---|
| Median reaction (to close) | +1.38% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 AGIO earnings events with a measured close landed between -0.54% and +2.95%; 72% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET | Press release | +0.16% | +1.46% | |
| Agios Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +8.63% | +11.09% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.17% | +2.81% | |
| Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET | Press release | +0.52% | +1.22% | |
| Agios Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -0.11% | +5.85% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +5.02% | +8.78% | |
| Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET | Press release | +0.00% | -1.86% | |
| Form 10-K AGIOS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +2.88% | +1.52% | |
| Agios Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -2.70% | +2.37% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -0.30% | +0.09% | |
| Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET | Press release | +0.13% | +0.29% | |
| Agios Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +1.17% | +0.87% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +1.10% | +1.99% | |
| Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | -6.37% | +5.96% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +1.51% | +4.07% | |
| Form 10-K AGIOS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.39% | -0.54% | |
| Agios Reports Business Highlights and Third Quarter 2024 Financial Results | Press release | +0.09% | -0.69% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.09% | -0.69% | |
| Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 | Press release | +0.38% | +1.31% | |
| Agios Reports Business Highlights and Second Quarter 2024 Financial Results | Press release | -3.03% | -0.85% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | -0.88% | +1.60% | |
| Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024 | Press release | +0.02% | +1.38% | |
| Agios Reports Business Highlights and First Quarter 2024 Financial Results | Press release | +2.38% | +2.95% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +2.38% | +2.95% | |
| Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 | Press release | +0.86% | +1.13% | |
| Form 10-K AGIOS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.14% | +3.26% | |
| Agios Reports Business Highlights and Third Quarter 2023 Financial Results | Press release | -0.28% | -2.33% | |
| Form 10-Q AGIOS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -0.28% | -2.33% | |
| Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023 | Press release | -0.69% | -1.29% |
Keep exploring
More AGIO: analyst actions → · SEC filings → · AGIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Midatech Pharma PLC - American Depositary Shares (MTP) | 492 | 0.00% | 41% |
| Stryker Corporation (SYK) | 491 | -0.09% | 39% |
| TEARLAB CORP (TEAR) | 488 | 0.00% | 43% |
| Odonate Therapeutics, Inc. (ODT) | 487 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.